Computational approaches to modeling drug transporters

被引:43
作者
Chang, C [1 ]
Swaan, PW [1 ]
机构
[1] Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
关键词
homology modeling; 3D-QSAR; pharmacophore; transporter;
D O I
10.1016/j.ejps.2005.09.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Computational modeling has advanced our understanding of drug absorption, tissue distribution, excretion and toxicity profiles by providing both direct and indirect knowledge of drug-transporter interactions that would otherwise be unavailable using experimental methods. Currently, two complementary approaches are available in modeling transporters: substrate-based and transporter-based methods. The transporter-based approach directly predicts the transporter's three-dimensional structure to assist in understanding the drug transport process, whereas substrate-based models infer such information by studying a group of substrates or inhibitors with measured activities. In this review, the available strategies in both transporter-based and substrate-based approaches are explained and illustrated with applications and case studies. With increasing computational power and continuously improving modeling algorithms, computational techniques can assist in further understanding transporter-substrate interactions as well as, the optimization of transporter-directed drug design. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:411 / 424
页数:14
相关论文
共 105 条
  • [71] Inhibitors of P-glycoprotein - Lead identification and optimisation
    Pleban, K
    Ecker, GF
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (02) : 153 - 163
  • [72] Homology model of the multidrug transporter LmrA from Lactococcus lactis
    Pleban, K
    Macchiarulo, A
    Costantino, G
    Pellicciari, R
    Chiba, P
    Ecker, GF
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (23) : 5823 - 5826
  • [73] Modulation of P-glycoprotein function and reversal of multidrug resistance by (-)-epigallocatechin gallate in human cancer cells
    Qian, F
    Wei, DZ
    Zhang, Q
    Yang, SL
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2005, 59 (03) : 64 - 69
  • [74] Molecular model of the neural dopamine transporter
    Ravna, AW
    Sylte, I
    Dahl, SG
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2003, 17 (5-6) : 367 - 382
  • [75] Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters
    Ravna, AW
    Sylte, I
    Dahl, SG
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (01) : 34 - 41
  • [76] Ravna AW, 2001, RECEPTOR CHANNEL, V7, P319
  • [77] Interactions of antidepressants with the serotonin transporter: a contemporary molecular analysis
    Roman, DL
    Walline, CC
    Rodriguez, GJ
    Barker, EL
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 479 (1-3) : 53 - 63
  • [78] Stability of membrane proteins: Relevance for the selection of appropriate methods for high-resolution structure determinations
    Rosenbusch, JP
    [J]. JOURNAL OF STRUCTURAL BIOLOGY, 2001, 136 (02) : 144 - 157
  • [79] Structural and functional analysis of the C-terminal STAS (sulfate transporter and anti-sigma antagonist) domain of the Arabidopsis thaliana sulfate transporter SULTR1.2
    Rouached, H
    Berthomieu, P
    El Kassis, E
    Cathala, N
    Catherinot, V
    Labesse, G
    Davidian, JC
    Fourcroy, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (16) : 15976 - 15983
  • [80] Common active site architecture and binding strategy of four phenylpropanoid P450s from Arabidopsis thaliana as revealed by molecular modeling
    Rupasinghe, S
    Baudry, J
    Schuler, MA
    [J]. PROTEIN ENGINEERING, 2003, 16 (10): : 721 - 731